Skip to main navigation
Skip to search
Skip to main content
Italian Ministry of Health Home
Home
Profiles
Research units
Projects
Research output
Search by expertise, name or affiliation
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial
NILVAD Study Group
Istituto di Ricerche Farmacologiche "Mario Negri"
Fondazione Don Carlo Gnocchi Onlus
A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)
IRCCS Multimedica
Centro San Giovanni di Dio - Fatebenefratelli
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
nilvadipine
100%
Alzheimer Disease
44%
Randomized Controlled Trials
38%
Mental Status and Dementia Tests
21%
Placebos
18%
Amyloid
9%
Dementia
8%
Cognitive Dysfunction
8%
National Institute of Neurological Disorders and Stroke (U.S.)
7%
Communication Disorders
7%
1,4-dihydropyridine
6%
Breakfast
6%
Regional Blood Flow
5%
Calcium Channel Blockers
5%
Cerebrovascular Circulation
5%
Intention
4%
Capsules
4%
Population
4%
Anti-Inflammatory Agents
3%
Research Personnel
3%
Therapeutics
3%
Clinical Trials
3%
Biomarkers
3%
Hypertension
3%
Demography
3%
Mortality
2%
Brain
2%